ARKGvsJDOC
ARK GENOMIC REVOLUTION ETF against JPMorgan Healthcare Leaders ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| ARKG | JDOC | |
|---|---|---|
| Expense ratio | 0.75% | 0.65% |
| Assets | $1.4B | $9048.54T |
| Net flow, 1 month | — | — |
| Net flow, 1 year | — | −$25K |
| Return, YTD | +86.4% | +2.9% |
| Return, 1 year | +81.1% | +10.6% |
| Avg daily volume | 3.9M | 241 |
| Holdings | 44 | 67 |
| Listed | Oct 31, 2014 | Oct 31, 2023 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS